Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 39.0 | 53 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 29.5 | 70 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 33.5 | 62 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 38.0 | 81 | |
RA2159 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 44.0 | 48 | |
RA2159 | Sigma A6730 | 3.0 | uM | 3 | HGF | 39.5 | 78 | ||||
N2586 | IL-6 | 100 | ug/mL | 3 | HGF | 59.0 | 80 | ||||
N2586 | PD184352 | 0.1 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 56.0 | 49 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 44.0 | 74 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 61.5 | 70 | |
N2586 | Tofacitinib | 0.3 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 39.0 | 58 | |
N2586 | IKK16 | 2.0 | uM | IL-6 | 100 | ug/mL | 3 | HGF | 40.0 | 67 | |
N2586 | Sigma A6730 | 3.0 | uM | 3 | HGF | 58.0 | 57 | ||||
RA2159 | IL-1 alpha | 100 | ng/mL | 3 | HGF | 74.0 | 80 | ||||
RA2159 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 62.5 | 60 | |
RA2159 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 63.0 | 88 | |
RA2159 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 84.0 | 72 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 78.0 | 67 | |
RA2159 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 44.0 | 66 | |
RA2159 | PI103 | 0.1 | uM | 3 | HGF | 36.0 | 67 | ||||
N2586 | IL-1 alpha | 100 | ng/mL | 3 | HGF | 129.0 | 71 | ||||
N2586 | PD184352 | 0.1 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 185.0 | 80 | |
N2586 | Lestaurtinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 141.0 | 61 | |
N2586 | Ruxolitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 166.0 | 50 | |
N2586 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 3 | HGF | 63.0 | 59 |